2023/12/27 by Fernandes Lopes, Patrícia, Pedrosa, Gustavo Rocha, Trigueiros, António +3
#head and neck #sarcomas #tumors
paper · doi:10.34631/sporl.2072
Objective: To identify prognostic factors for Head and Neck Soft Tissue Sarcoma. Assess survival according to sublocation and treatment. Study design: Observational retrospective study Material/methods: Analysis of patients data with Head and Neck Soft Tissue Sarcoma followed at the ENT department at IPO-LFG between 1980 and 2022. Results: 59 patients (64% men) with a mean age of 47,2 years were selected. Chondrosarcoma and rhabdomyosarcoma were the most diagnosed and the larynx was the most affected local. 83% were operated; 28%% relapsed locally; and 10% had metastasis. 17% of patients died from the disease. The patients who received RT exclusively died. The disease-specific survival rate at the 5th year was 83%, with the spindle cell sarcoma having the worst results. Conclusion: Head and Neck Sarcomas have worse outcomes than other locations. Spindle cell sarcoma and primary treatment with RT were associated with higher mortality. Early surgical treatment is essential.